The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette
Clinical trial NCT05205811 · COMPLETED
Trial details
- NCT number
- NCT05205811
- Sponsor
- Rose Research Center, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2025-06-19
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.